ATA 2015 ATA Clinical Management Guidelines on Medullary Thyroid Cancer and Pediatric Thyroid Cancer - Highlights, Controversies and Consenus

Program: Pre-Conference Events
Clinical Session
Wednesday, March 4, 2015: 12:00 PM-6:00 PM
Room 6A (San Diego Convention Center)
**This session is eligible for CME credit**

Registration is required for this session:
Registration Rates:

  • ATA/ENDO members - $149
  • Non-members - $169 
  • Trainees - $59

Full Program
  • ATA PTC_MTC Guidelines Satellite AGENDA_1.5.2015.docx (149.9 kB)
  • The American Thyroid Association (ATA) assembles groups of expert clinicians and scientists to evaluate published papers and recommend evidence-based guidelines for the diagnosis and managmeent of thyroid cancer. Medullary thyroid carcinoma (MTC) accounts for 1-2% of thyroid cancers in the United States. The 2014 ATA MTC guidelines have been developed to assist clinicians of all specialities in the management of patients with MTC. Importantly, guidelines focused on children and the managment of thyroid nodules and cancers has not been previously addressed. Therapy that may be recommended for an adult may not be appropriate for a child who is at higher risk for long-term harm from over-aggressive treatment. For these reasons, unique guidelines for children and adolescents with thyroid tumors are needed.

    Authors from the international community of thyroid specialists in endocrinology, thyroid cancer, pediatric endocrinology and thyroid surgery will discuss two sets of newly published ATA guidelines with special focus on the:

    • ATA Medullary Thyroid Cancer Guidelines revised
    • ATA Clinical Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
    • Case based applications of both sets of guidelines
    See more of: Pre-Conference Events